要闻！小米SU7澎湃车机系统OTA升级：新增城市领航功能，优化人车家全生态体验

小米SU7澎湃车机系统OTA升级：新增城市领航功能，优化人车家全生态体验

北京，2024年6月17日 - 今日，小米汽车宣布，旗下SU7系列车型迎来1.2.0版本OTA升级，为用户带来一系列新功能和体验优化。此次升级最引人注目的便是城市领航辅助功能的扩展，目前已在北京、上海、广州、深圳、杭州、武汉、成都、西安、南京、苏州等十个城市的核心区域主要道路开通。

城市领航功能

城市领航辅助功能是小米汽车自主研发的智能驾驶辅助功能，可于高速公路或城市快速路等场景下自动引导车辆行驶，减轻驾驶员负担。此次升级后，该功能的覆盖范围得到显著扩展，可为更多用户提供便利。

此外，城市领航辅助功能还新增了以下优化：

• 提高了识别交通标志标示的准确性；
• 优化了变道策略，使变道操作更加平顺；
• 增强了对行人和骑行者的识别能力。

小憩模式

为提升用户舒适性，此次升级还新增了驻车空间的“小憩模式”。开启该模式后，车辆空调、座椅按摩等功能将自动调整至舒适状态，并提供快捷闹钟、座椅调节和记忆功能，以及小米手机的勿扰模式联动，让用户可以在车内享受惬意的休憩时光。

人车家全生态体验

此次升级还对人车家全生态体验进行了优化，包括：

• 后排Pad地图功能增强，可显示更多信息；
• 小米对讲机3支持方向盘按键控制，操作更加便捷；
• 车载系统支持连接蓝牙游戏手柄，实现大屏游戏体验；
• 智能手机连接车辆热点后，可通过App快速分享地点到车机；
• 智能设备App也支持导入更多米家设备。

OTA升级方法

小米SU7车主可通过以下方式进行OTA升级：

• 车机端：在系统设置中选择版本更新，点击“立即更新”；
• 小米汽车App：进入“车辆”页中的版本更新提示，点击“立即更新”。

此次OTA升级不仅提升了小米SU7的智能驾驶体验，也进一步强化了小米汽车与用户日常生活的无缝连接，展现了小米汽车以用户为中心的理念。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.